In The Research Briefing: - The methodological challenges faced in psychedelic clinical trials (and how to fix them) - Mystical experiences in recreational use associated with improvements in wellbeing - A novel 5-MeO-DMT formulation proves to be safe in Phase I trial
For links to all the stories featured on this weeks episode check out the written briefing at reportonpsychedelics.com/category/weekly
Never miss an episode by signing up for our weekly newsletter: https://reportonpsychedelics.com/